Clive Page is a Professor of Pharmacology, King’s College London and Director of The Pulmonary Pharmacology Unit, King’s College London. Clive’s main research interests are in the pharmacology of inflammation and respiratory disease and he has published over 250 scientific papers. Clive was the co-founder and previous Chairman of the Board of Verona Pharma plc, an AIM listed Company developing new drugs for the treatment of Respiratory Diseases. He is a Non Executive Director of Babraham Biotechnology Ltd, as well as being a Trustee of the Babraham Institute in Cambridge and a Non Executive Director of the Board of ImmunoRegulation Ltd, PreP Biopharma and EpiEndo.

Clive started his early career in the Pharmaceutical Industry at Sandoz Ltd, Basel, Switzerland and regularly consults to both the Pharmaceutical and Biotech Industry.  Clive has previously held Non Executive Board positions at Cardiome in Canada and Stirling Products Ltd in Perth, Australia. Clive is a recent former Chairman of the Animal Science Group of the Society of Biology and has contributed widely to the public debate about the use of animals in Research. He was awarded the Society of Biology President’s Medal in 2012 for an outstanding contribution to the life sciences over the previous year.   He is a Fellow of the Royal Society of Biology and an Honorary Fellow and President Elect of the British Pharmacological Society.  In 2017, Clive was awarded an OBE for Services to Pharmacology